(19)

(11)

EP 4 499 695 A1

(12)

(43) Date of publication: 05.02.2025 Bulletin 2025/06 (21) Application number: 23718890.9 (22) Date of filing: 28.03.2023

(51) International Patent Classification (IPC):  C07K 16/28(2006.01) (52) Cooperative Patent Classification (CPC): C07K 16/2803; C07K 2317/52; C07K 2317/524; C07K 2317/526; C07K 2317/75 (86) International application number: PCT/US2023/016569 (87) International publication number: WO 2023/192282 (05.10.2023 Gazette 2023/40)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 28.03.2022 US 202263324425 P (71) Applicant: Denali Therapeutics Inc. South San Francisco, California 94080 (US)

(72) Inventors: DI PAOLO, Gilbert South San Francisco, California 94080 (US) MONROE, Kathryn M. South San Francisco, California 94080 (US) SUH, Jung H. South San Francisco, California 94080 (US) VAN LENGERICH, Bettina South San Francisco, California 94080 (US) XIA, Dan South San Francisco, California 94080 (US) (74) Representative: J A Kemp LLP  80 Turnmill Street London EC1M 5QU London EC1M 5QU (GB)